Isoform-specific Purification and Substrate Specificity of the 5′-AMP-activated Protein Kinase*
B. Michell,D. Stapleton,K. Mitchelhill,C. House,Frosa Katsis,L. Witters,B. Kemp
DOI: https://doi.org/10.1074/jbc.271.45.28445
IF: 5.485
1996-11-08
Journal of Biological Chemistry
Abstract:The 5′-AMP-activated protein kinase (AMPK) mediates several cellular responses to metabolic stress. Rat liver contains at least two isoforms of this enzyme, either α1 or α2 catalytic subunits together with β and γ noncatalytic subunits in a trimeric complex. The α1 isoform is purified using a peptide substrate affinity chromatography column with ADR1 (222-234)P229 (LKKLTRRPSFSAQ), corresponding to the cAMP-dependent protein kinase phosphorylation site in the yeast transcriptional activator of the ADH2 gene, ADR1. This peptide is phosphorylated at Ser230 by AMPK α1 with a Km of 3.8 μM and a Vmax of 4.8 μmol/min/mg compared to the commonly used rat acetyl-CoA carboxylase (73-87)A77R86-87 peptide substrate, HMRSAMSGLHLVKRR, with a Km of 33.3 μM and a Vmax of 8.1 μmol/min/mg. Thus, the AMPK exhibits some overlapping specificity with the cAMP-dependent protein kinase. The rat liver AMPK α1 isoform has a Kcat ∼250-fold higher than the AMPK α2 isoform isolated from rat liver. The AMPK α1 isoform readily phosphorylates peptides corresponding to the reported AMPK phosphorylation sites in rat, chicken, and yeast acetyl-CoA carboxylase and rat hydroxymethylglutaryl-CoA reductase but not phosphorylase kinase. Based on previous peptide substrate specificity studies (Dale, S., Wilson, W. A., Edelman, A. M., and Hardie, G. (1995) FEBS Lett. 361, 191-195) using partially purified enzyme and variants of the peptide AMARAASAAALARRR, it was proposed that the AMPK preferred the phosphorylation site motif Φ(X, β)XXS/TXXXΦ (Φ, hydrophobic; β, basic). In good AMPK α1 peptide substrates, a hydrophobic residue at the P−5 position is conserved but not at the P+4 position. Oxidation of the Met residues in the rat acetyl-CoA carboxylase (73-87)A77R86-87 peptide increased the Km 6-fold and reduced the Vmax to 4% of the reduced peptide.